Abstract | BACKGROUND: MATERIAL/METHODS: RESULTS: CONCLUSIONS:
Candidemia in children who undergo surgical treatment of congenital heart defects is an important factor that can influence final clinical results. Caspofungin may be an effective therapeutic option when treating candidemia in children after extensive cardiosurgical procedures.
|
Authors | Radoslaw Jaworski, Ninela Irga, Ireneusz Haponiuk, Maciej Chojnicki, Elzbieta Arlukowicz, Mariusz Steffek, Mariusz Sroka, Katarzyna Gierat-Haponiuk, Jacek Juscinski, Lucyna Palkowska, Aneta Sendrowska, Wojciech Kosiak |
Journal | Medical science monitor : international medical journal of experimental and clinical research
(Med Sci Monit)
Vol. 17
Issue 5
Pg. PH35-9
(May 2011)
ISSN: 1643-3750 [Electronic] United States |
PMID | 21525820
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Antifungal Agents
- Echinocandins
- Lipopeptides
- C-Reactive Protein
- Caspofungin
|
Topics |
- Antifungal Agents
(therapeutic use)
- C-Reactive Protein
(metabolism)
- Candidemia
(blood, drug therapy, etiology)
- Cardiac Surgical Procedures
(adverse effects)
- Caspofungin
- Child
- Echinocandins
(therapeutic use)
- Female
- Heart Defects, Congenital
(surgery)
- Humans
- Infant
- Leukocyte Count
- Lipopeptides
|